Evidence map›Paper›PMID 42514925›Full record

ArticlePharmaceutics2026

Proteomic Stability and Ex Vivo Compatibility of a Processed Phospholipoproteic Secretome-Derived Formulation.

Ramón Gutiérrez-Sandoval, Francisco Gutiérrez-Castro, Natalia Muñoz-Godoy, Ider Rivadeneira, Andy Lagos, Jordan Iturra, Francisco Krakowiak, Ignacio Muñoz, Andrés Toledo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ramón Gutiérrez-SandovalOGRD Alliance LLC, 6900 Tavistock Lakes Boulevard, Suite 400, Lake Nona, Orlando, FL 32827, USA.ORCID 0009-0004-8428-9549
Francisco Gutiérrez-CastroDepartment of Cancer Research, Flowinmunocell-Bioexocell Group, 08028 Barcelona, Spain.
Natalia Muñoz-GodoyDepartment of Cancer Research, Flowinmunocell-Bioexocell Group, 08028 Barcelona, Spain.
Ider RivadeneiraDepartment of Outreach and Engagement Programs, OGRD Consortium, Charlestown KN0802, Saint Kitts and Nevis.
Andy LagosDepartment of Outreach and Engagement Programs, OGRD Consortium, Charlestown KN0802, Saint Kitts and Nevis.
Jordan IturraDepartment of Outreach and Engagement Programs, OGRD Consortium, Charlestown KN0802, Saint Kitts and Nevis.
Francisco KrakowiakHistopathology Laboratory, Bioclas, Concepción 4030000, Chile.
Ignacio MuñozDepartment of Outreach and Engagement Programs, OGRD Consortium, Charlestown KN0802, Saint Kitts and Nevis.
Andrés ToledoOGRD Alliance LLC, 6900 Tavistock Lakes Boulevard, Suite 400, Lake Nona, Orlando, FL 32827, USA.

Funding

Fundación Biotech FB-20222-0871
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cryopreservationdia-PASEFextracellular lipid–protein preparationslabel-free quantitative proteomicslive-cell kinetic imaginglyophilizationphospholipoproteic secretome-derived formulationprocessing stabilityshort-term ex vivo compatibilitytimsTOF Pro

Identifiers

PMID42514925
PMCPMC13416489

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.